LSE - Delayed Quote GBp
Belluscura plc (BELL.L)
0.8500
0.0000
(0.00%)
At close: June 13 at 4:12:12 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Robert Rauker | CEO & Director | 406.29k | -- | 1965 |
| Mr. Anthony Stephen Dyer FMCA | Company Secretary | 195.28k | -- | 1969 |
| Mr. Keith Cook | Vice President of Operations | -- | -- | -- |
| Mr. Jim Clement | Head of Commercial Strategy | -- | -- | -- |
Belluscura plc
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 35
Description
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Corporate Governance
Belluscura plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
June 25, 2025 at 10:59 AM UTC - June 30, 2025 at 12:00 PM UTC
Belluscura plc Earnings Date
Recent Events
Recent Events Information Not Available